Serum LDH value as a predictor of clinical outcome in acute myelogenous leukaemia of the elderly

British Journal of Haematology

Volumn 92, Issue 3, 1996, Pages 627-631

  Ferrara, Felicetto ^a,c   Mirto, Salvatore ^b  

^a CARDARELLI HOSPITAL   (Italy)

^b VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^c NONE   (Italy)

Author keywords

Acute myelogenous leukaemia; Elderly patients; Prognostic factors; Serum LDH

Indexed keywords

CYTARABINE; IDARUBICIN; LACTATE DEHYDROGENASE;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030009224     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.00398.x     Document Type: Article

References (27)

1. Baudard, M., Marie, J.P., Cadiou, M., Viguié. F. & Zittoun, R. (1994) Acute myelogenous leukaemia in the elderly: retrospective study of 235 patients. British Journal of Haematology, 86, 82-91.
2. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia. Annals of Internal Medicine, 105, 626-669.
3. Bloomfield, C.D., Lawrence, D., Arthur, D.C., Berg, D.T., Schiffer, C.A. & Mayer, R.J. (1994) Curative impact of intensification with high-dose cytarabine (HiDAC) in acute myeloid leukemia (AML) varies by cytogenetic group. Blood, 84, (Suppl. 1), 111a.
4. Brincker, H. (1985) Estimate of overall treatment results in acute nonlymphocytic leukemia based on age specific rates of incidence and of complete remission. Cancer Treatment Reports, 69, 5-11.
5. Brito-Bapapulle, F., Catovsky, D. & Galton, D.A.G. (1987) Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia. British Journal of Haematology, 66, 445-450.
6. Cartwright, R.A. & Staines, A. (1992) Acute leukaemias. Epidemiology of Haematological Diseases, Part 1 (ed. by A. T. Fleming). Bailliere's Clinical Haematology, 5, 1-26.
7. Cartwright, R.A. & Staines, A. (1992) Acute leukaemias. Epidemiology of Haematological Diseases, Part 1 (ed. by A. T. Fleming). Bailliere's Clinical Haematology, 5, 1-26.
8. Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Statistical Society, B, 34, 187-220.
9. Dombret, H., Chastang, C., Fenaux, P., Reiffers, J., Bordessoule, D., Bouabdallah, R., Mandelli, F., Ferrant, A., Auzanneau, G., Tilly, H., Yver, A. & Degos, L. (1995) A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. New England Journal of Medicine, 332, 1678-1683.
10. Ferrara, F., Mele, G., Mettivier, V., Mirto, R. & Cimino, R. (1992) Idarubicin in the treatment of acute myelogenous leukemia in the elderly. Leukemia and Lymphoma, 7, (Suppl. 2), 4-7.
11. Groupe Francaise de Morphologie Hematologique (1987) French registry of acute leukemia and myelodysplastic syndrome: age distribution and hemogram analysis of the 4496 cases recorded during 1982-1983 and classified according to FAB criteria. Cancer, 60, 1385-1394.
12. Hamblin, T.H. (1995) Disappointments in treating acute leukemia in the elderly. New England Journal of Medicine, 332, 1712-1713.
13. Heinecke, A., Sauerland, M.C. & Buchner, T. (1994) CART: a method to detect prognostic subgroups in AML. Blood, 84, (Suppl. 1), 310a.
14. Heinemann, V. & Jehn, U. (1991) Acute myeloid leukemia in the elderly: biological features and search for adequate treatment. Annals of Hematology, 63, 179-188.
15. Heyll, A, Aul, C., Gogolin, F., Runde, V., Sohngen, D., Meckenstock, G., Wolf, H.H., Zahner, J., Burk, M., Winkelmann, M. & Schneider, W. (1994) Results of conventional-dose cytosine-arabinoside and idarubicin in elderly patients with acute myeloid leukemia. Annals of Hematology, 68, 279-283.
16. Johnson, P.R.E. (1993) Acute myeloid leukaemia in the elderly: biology and treatment. British Journal of Haematology, 83, 1-6.
17. Johnson, P.R.E., Hunt, L.P. & Liu Yin, A.L. (1993) Prognostic factors in elderly patients with acute myeloid leukaemia: development of a model to predict survival. British Journal of Haematology, 85, 300-306.
18. Kantarjan, H.M., Beran, M., Ellis, A., Zwelling, L., O'Brien, S., Cazenave, L., Koller, C., Rios, M.B., Plunkett, W., Keating, M.J. & Estey, K.H. (1993) Phase 1 study of topotecan, a new topoisomerase 1 inhibitor, in patients with refractory or relapsed acute leukemia. Blood, 81, 1146-1151.
19. Kaplan, E.L. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
20. Leoni, F., Ciolli, S., Giuliani, G., Pascarella, A., Caporale, R., Salti, F., Cervi, L. & Rossi Ferrini, P.L. (1995) Attenuated dose idarubicin in acute myeloid leukaemia of the elderly: pharmacokinetic study and clinical results. British Journal of Haematology, 90, 169-174.
21. List, A.F., Spier, C., Greer, J., Wolff, S., Hutter, J., Dorr, R., Salmon, S., Futscher, B., Baier, M. & Dalton, W. (1993) Phase I/II trial of cyclosporin as a chemotherapy-resistance modifier in acute leukemia. Journal of Clinical Oncology, 11, 1652-1660.
22. Liu Yin, J.A., Johnson, P.R.E., Davies, J.M., Flanagan, N.G., Gorst, D.W. & Lewis, M.J. (1991) Mitozantrone and cytosine arahinoside in elderly patients with acute myeloid leukaemia. British Journal of Haematology, 79, 415-420.
23. Pui, C-H., Dodge, R.K., Dahl, G.V., Rivera, G., Look, T., Kalwinsky, D., Bowman, W.P., Ochs, J., Abromowitc, M., Mirro, J. & Murphy, S.B. (1985) Serum lactic dehydrogenase level has prognostic value in childhood acute lymphoblastic leukemia. Blood, 66, 778-782.
24. Rowlings, P.A., Keating, A., Horowitz, M.M., Zhang, M.J. & Armitage, J.O. (1994) Autotransplants for acute myelogenous leukemia (AML) in North America. Proceedings of the American Society of Clinical Oncology, 13, 305a.
25. Stone, R.M., Berg, D.T., George, S.L., Dodge, R.K., Paciucci, P.A., Schulman, P., Lee, E.J., Moore, J.O., Powell, B.L. & Schiffer, C.A. (1995) Granulocyte-macrophagc colony stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. New England Journal of Medicine, 332, 1671-1677.
26. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non Hodgkin's lymphoma. New England Journal of Medicine, 329, 987-994.
27. Vidriales, M.B., Orfao, A., Lòpez-Berges, M.C., GonzÖlez, M., Lòpez-Macedo, A., Ciudad, J., Lòpez, A., Garcia, M.A., Hernandez, J., Borrego, D. & San Miguel. J.F. (1995) Prognostic value of S-phase cells in AML patients. British Journal of Haematology, 89, 342-348.